Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.

MLA

Gallet, Quentin, et al. “Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.” American Journal of Geriatric Psychiatry, vol. 32, no. 6, June 2024, pp. 665–77. EBSCOhost, https://doi.org/10.1016/j.jagp.2023.10.002.

APA

Gallet, Q., Bouteloup, V., Locatelli, M., Habert, M.-O., Chupin, M., Campion, J.-Y., Michels, P.-E., Delrieu, J., Lebouvier, T., Balageas, A.-C., Surget, A., Belzung, C., Arlicot, N., Ribeiro, M.-J. S., Gissot, V., El-Hage, W., Camus, V., Gohier, B., & Desmidt, T. (2024). Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort. American Journal of Geriatric Psychiatry, 32(6), 665–677. https://doi.org/10.1016/j.jagp.2023.10.002

Chicago

Gallet, Quentin, Vincent Bouteloup, Maxime Locatelli, Marie-Odile Habert, Marie Chupin, Jacques-Yves Campion, Pierre-Emmanuel Michels, et al. 2024. “Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.” American Journal of Geriatric Psychiatry 32 (6): 665–77. doi:10.1016/j.jagp.2023.10.002.